Óscar Rodríguez Faba

Surgical uro-oncologist at @FPuigvert. Editor in chief @actasurologicas official journal of @InfoAeu.🇪🇸

[Óscar Rodríguez Faba @RodriguezFaba]

The latest advances in genitourinary oncology deserve debate!!
Join the discussion. Challenge the evidence.
SAVE THE DATE!!!

[actasurologicas @actasurologicas]

Pasado y presente del cribado del cáncer de próstata en la Unión Europea
https://t.co/SXSRw3VR9B

[actasurologicas @actasurologicas]

Transferencia de competencias de los videojuegos a la cirugía robótica y laparoscópica: ¿es posible en la sociedad actual?
https://t.co/urxNoNQPKm

[Óscar Rodríguez Faba @RodriguezFaba]

Our News systematic review @FPuigvert highlights that pathological response after neoadjuvant therapy may provide valuable prognostic information in metastatic RCC, often beyond what radiological assessment alone can capture.
Read here:

https://t.co/KqF32h8Q01

[GUARD Consortium @GuardConsortium]

🔬 ¡Ya está aquí! El GUARD International Symposium 2026 se celebra los días 16-18 de septiembre en Madrid. Tres días de ciencia, debate y avances en uro-oncología. 

🗓️ ¡Consulta el programa preliminar y reserva tu plaza!👇 https://t.co/esjsktqokn

#guardsymposium2026 @DrFelixGuerrero @cdanicas @dralvaropinto @drenriquegrande @fcounago @docjavip @BerUrologia @DrJaVallejo @Maroto5Pablo @nachoduranm @RodriguezAntona @AnaPlatabello1 @Uro_Oncologist @F_lopez_campos

[Óscar Rodríguez Faba @RodriguezFaba]

¡Enhorabuena por la magnífica organización y a los #ResidentesSMU por las magníficas presentaciones y alto nivel científico! @smumexico @FPuigvert @InfoAeu @CAU_URO @ResidentesCAU

[Alex Hermen @AlexHermen]

¡Gracias por participar! @RodriguezFaba @FEcheverriaUro 👏🏻🙌🏻

[Alex Hermen @AlexHermen]

¡Gracias por participar! @RodriguezFaba @FEcheverriaUro 👏🏻🙌🏻

[Óscar Rodríguez Faba @RodriguezFaba]

New publication in the Residents’ Section of @actasurologicas on the retrosigmoid ileal conduit after radical cystectomy.

📄 https://t.co/iRV9lx8GN0

#Urology #BladderCancer

[Óscar Rodríguez Faba @RodriguezFaba]

Un honor vivir estos partidos académicos junto a los #ResidentesSMU como invitado juez. Listo para compartir, aprender y disfrutar cada debate que fortalece nuestra práctica urológica. ⚽🩺👏
@FPuigvert @ResidentesAEU @ResidentesCAU @InfoAeu @actasurologicas

[Residentes SMU 🇲🇽 @Residentes_SMU]

⚽🩺 ¡El #BoardCup26 ha sido un éxito y nuevos equipos se han unido a la competición!

Nuestros #ResidentesSMU saben que cada intervención es una jugada estratégica y cada debate, una oportunidad de fortalecer la práctica urológica. ¡Acompáñanos a vivir los próximos partidos académicos!

📆 Sábado, 23 de mayo, 2026.
🕗 08:00 hrs.
🎥 Auditorio SMU | Streaming en https://t.co/qC0HSKoZYR y Facebook

#SMU26 #JuntosTrascendemos #Urología

[OncoDaily @oncodaily]

𝐇𝐨𝐰 𝐈 𝐓𝐫𝐞𝐚𝐭 𝐁𝐥𝐚𝐝𝐝𝐞𝐫 𝐂𝐚𝐧𝐜𝐞𝐫 𝐢𝐧 𝟐𝟎𝟐𝟔

The final session of “How I Treat Bladder Cancer in 2026” brought together leading experts to discuss the future of bladder cancer care, highlighting advances in non–muscle-invasive disease management, radiotherapy innovations, and the global challenges shaping the field.

🔹 Óscar Rodríguez Faba (@RodriguezFaba) presented on non–muscle-invasive bladder cancer, exploring current treatment approaches, evolving management strategies, and key considerations in optimizing patient care.
🔹 Kent W. Mouw (@mouwlab) discussed “Advances in Radiation for MIBC,” focusing on the latest developments in radiotherapy techniques and their role in improving outcomes for patients with muscle-invasive bladder cancer.
🔹 The session concluded with a panel discussion, “The Future of Bladder Cancer Care: Innovations, Challenges, and Global Perspectives,” featuring summit faculty members sharing insights on emerging therapies, multidisciplinary collaboration, and the future direction of bladder cancer treatment worldwide.

As bladder cancer treatment continues to evolve, global collaboration and innovation remain essential to improving patient outcomes and advancing personalized care. Sessions like these highlight the importance of multidisciplinary expertise in shaping the future of oncology.

@8_8Malu

[GUARD Consortium @GuardConsortium]

📅 SAVE THE DATE

3rd Multidisciplinary Meeting to Discuss Gaps in Genitourinary Tumors

📍Barcelona
📅 9 y 10 de julio
👥 Coordinan Dr. Pablo Maroto, Dr. Óscar Rodríguez Faba y Dra. Gemma Sancho

Un encuentro multidisciplinar centrado en necesidades no cubiertas y retos actuales en tumores GU.

#GUARDConsortium #GUOncology @DrFelixGuerrero @cdanicas @dralvaropinto @drenriquegrande @fcounago @docjavip @BerUrologia @DrJaVallejo @Maroto5Pablo @nachoduranm @RodriguezAntona @AnaPlatabello1

🔗 Más información:
https://t.co/hz8s4ZrSGO

[Óscar Rodríguez Faba @RodriguezFaba]

📢 Taller de @actasurologicas en #CNU2026

Lectura Crítica Aplicada a Urología Clínica
📅 11 junio 2026
🕒 15:30–17:30 h

Aprende a interpretar estudios clínicos, detectar limitaciones metodológicas y valorar la aplicabilidad real.

Inscripción:
https://t.co/dUxPYkYUqK

[Óscar Rodríguez Faba @RodriguezFaba]

@FPuigvert
@OncoSantPau
@actasurologicas
@CAU_URO
@InfoAeu

[OncoDaily @oncodaily]

We are pleased to announce Dr. Óscar Rodríguez Faba as a Speaker at How I Treat Bladder Cancer 2026.

Dr. Rodríguez Faba is a faculty member in the Department of Urology at Fundació Puigvert and part of the multidisciplinary urologic oncology team at Fundació Puigvert–Sant Pau hospitals. His clinical and research work focuses on genitourinary malignancies, minimally invasive surgery, biomarker research, and risk stratification in bladder and renal cancer.

His expertise in urologic oncology, precision medicine, and bladder cancer research will bring valuable perspective to this international educational discussion on contemporary bladder cancer management.

Register here: https://t.co/wqEhurJtKN

Additional faculty announcements will follow soon.

#HowITreatBladderCancer #BladderCancer #GUOncology #UrologicOncology

[OncoDaily @oncodaily]

We are pleased to announce Dr. Óscar Rodríguez Faba as a Speaker at How I Treat Bladder Cancer 2026.

Dr. Rodríguez Faba is a faculty member in the Department of Urology at Fundació Puigvert and part of the multidisciplinary urologic oncology team at Fundació Puigvert–Sant Pau hospitals. His clinical and research work focuses on genitourinary malignancies, minimally invasive surgery, biomarker research, and risk stratification in bladder and renal cancer.

His expertise in urologic oncology, precision medicine, and bladder cancer research will bring valuable perspective to this international educational discussion on contemporary bladder cancer management.

Register here: https://t.co/wqEhurJtKN

Additional faculty announcements will follow soon.

#HowITreatBladderCancer #BladderCancer #GUOncology #UrologicOncology

[actasurologicas @actasurologicas]

La revista Actas Urológicas Españolas reconoce al Dr. Félix Guerrero-Ramos como Revisor del mes de mayo. Su implicación en la revisión es clave para garantizar el rigor científico y la calidad de los contenidos publicados.
@DrFelixGuerrero
#AEU #ActasUrológicasEspañolas

[Ashish M. Kamat, MD, MBBS @UroDocAsh]

No patient should receive more treatment than they need - or less than they deserve.

But: The goal is not to avoid surgery at all costs. For *selected* patients with recurrent low-grade IR NMIBC, intravesical neoadjuvant chemotherapy may offer a real alternative to repeated TURBT - preserving the bladder, reducing surgical burden, and improving quality of life.

#BladderCancer @GustavoVillold4 @joanfundi @rodriguezfaba @fcandiagaston #AUA26

[Óscar Rodríguez Faba @RodriguezFaba]

This month in @actasurologicas https://t.co/lxMRYsQont

We evaluated the reliability of NLP & Big Data (Savana®) in patients lo q-eisk

📊 Results were comparable to our institutional database, although expert validation remains essential.

#Urology #ProstateCancer #AI #NLP

[Óscar Rodríguez Faba @RodriguezFaba]

#Villadepalos #Bierzo #León

[Pueblos Mágicos de España @pueblosmagicos]

El rincón de Pontevedra que comparte distinción con Altamira y El Escorial: uno de los lugares más mágicos de España 🪄 🪄 🪄 https://t.co/zYtONYFB6v

[Óscar Rodríguez Faba @RodriguezFaba]

🚨 New editorial published in @ActasUrolEsp:
https://t.co/MdFxNx1FFM

“Can We Use Intense Intravesical Neoadjuvant Chemotherapy to Treat Recurrent LG-IR NMIBC and Avoid TURBT?”
✓ Intensive intravesical MMC
✓ Chemoablation
✓ UGN-102
✓ TAR-200/TAR-210

[Óscar Rodríguez Faba @RodriguezFaba]

Check out this article: Dr. Óscar Rodriguez Faba, urólogo: "Cualquier episodio de sangre en la orina debe evaluarse siempre" - https://t.co/UapQt1p0Gq

[Felipe Couñago PhD @fcounago]

📢 New publication from SEOR-URONCOR 🇪🇸 in @actasurologicas

Our position paper supports the role of radiation oncologists in prescribing PARP inhibitors in advanced PCa🧬

✅ Multidisciplinary care
✅ Precision oncology
✅ Patient-centered decisions

🔗 https://t.co/eI1e1npQwH